Literature DB >> 25152998

Causes of mortality in neurofibromatosis type 2.

Rabih Aboukais1, Fahed Zairi1, Nicolas-Xavier Bonne2, Marc Baroncini1, Stéphane Schapira2, Christophe Vincent2, Jean-Paul Lejeune1.   

Abstract

OBJECT: The causes of mortality in neurofibromatosis type 2 (NF2) patients are poorly studied in the literature. Our study aimed to fit this gap by analyzing the main causes of death in this population.
METHODS: This study is the retrospective review of prospectively collected data of 80 patients with NF2 disease followed in Lille University Hospital between 1987 and 2011. Demographical data, diagnosis criteria, and cause of death were recorded.
RESULTS: There were 45 men and 35 women, with a mean age at diagnosis of 27.2 years (range: 6-73 years; SD: ± 15.4). Sixty-eight patients met Manchester criteria and the others had an identified mutation in the NF2 gene which confirmed the diagnosis. Of all patients, we noted 7 deaths. The mean age at diagnosis of dead patients was 26 years. The mean age of death was 38.9 years. The causes of death were suicide in 1 patient, hematoma after surgical removal of grade IV vestibular schwannoma in 1 patient, aspiration pneumonia after swallowing disturbances in 3 patients, intracranial hypertension related to growth of multiple meningiomas in 1 patient, and brachial plexus sarcoma grade 3 in the last patient.
CONCLUSION: NF2 is a serious disease that can quickly be life-threatening. The presence of lower cranial nerves schwannomas is a poor prognostic factor, and radiosurgery should be considered for their treatment, as surgical removal often worsens the swallowing disturbances. A psychological support should also be provided.

Entities:  

Keywords:  NF2; meningioma; schwannoma; spinal tumor; tumor

Year:  2014        PMID: 25152998     DOI: 10.3109/02688697.2014.952266

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  Effect of AR42 in Primary Vestibular Schwannoma Cells and a Xenograft Model of Vestibular Schwannoma.

Authors:  Carly Misztal; Olena Bracho; Esperanza Bas; Michael Estivill; Michael E Ivan; Jacques Morcos; Rita Bhatia; Fred Telischi; Xue-Zhong Liu; Sakir H Gultekin; Cristina Fernandez-Valle; Christine T Dinh
Journal:  Otol Neurotol       Date:  2022-07-01       Impact factor: 2.619

2.  Multiple Schwannomas of the Spine: Review of the Schwannomatosis or Congenital Neurilemmomatosis: A Case Report.

Authors:  Sang-Hoon Lee; Se-Hoon Kim; Bum-Joon Kim; Dong-Jun Lim
Journal:  Korean J Spine       Date:  2015-06-30

3.  CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.

Authors:  Julianne Huegel; Christine T Dinh; Maria Martinelli; Olena Bracho; Rosa Rosario; Haley Hardin; Michael Estivill; Anthony Griswold; Sakir Gultekin; Xue-Zhong Liu; Cristina Fernandez-Valle
Journal:  Oncotarget       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.